{"infobox":{"dc_creator":"Mart-bkr","dc_date_year":2015,"dc_description":"Beroepsmatige blootstelling aan adriamycine kan leiden tot kanker. De Gezondheidsraad beveelt aan om \u2018deze stof te beschouwen als kankerverwekkend voor de mens\u2019 (categorie 1B). De Gezondheidsraad is echter van mening dat wegens gebrek aan adequate humane en dierexperimentele gegevens het niet mogelijk is om de extra kans op kanker na blootstelling aan adriamycine exact te berekenen. Dit schrijft de Gezondheidsraad in een advies dat vandaag is aangeboden aan de minister van Sociale Zaken en Werkgelegenheid.","dc_identifier":"nl.oorg10218.2e.2015.57","dc_publisher":"oorg10218","dc_publisher_name":"Gezondheidsraad","dc_source":"https://www.gezondheidsraad.nl/documenten/adviezen/2015/03/18/adriamycine","dc_title":"Adriamycine","dc_type":"2e","dc_type_description":"2e - Advies","foi_decisionDate":"2015-03-18","foi_extraMetadata":{},"foi_fairiscoreVersions":{"v1":3,"v2":3},"foi_files":[{"dc_format":"application/pdf;charset=UTF-8","dc_identifier":"nl.oorg10218.2e.2015.57.doc.2","dc_source":"https://www.gezondheidsraad.nl/binaries/gezondheidsraad/documenten/adviezen/2015/03/18/adriamycine/201506Adriamycin.pdf","dc_title":"advies Adriamycine","dc_type":"bijlage","foi_doc_missing":1,"foi_fairiscoreVersions":{"v1":2,"v2":1},"foi_fileName":"201506Adriamycin.pdf","foi_nrPages":55},{"dc_format":"text/html","dc_identifier":"nl.oorg10218.2e.2015.57.doc.1","dc_source":"https://www.gezondheidsraad.nl/documenten/adviezen/2015/03/18/adriamycine","dc_title":"Webpagina: Adriamycine","dc_type":"bijlage","foi_doc_missing":1,"foi_fileName":"adriamycine.html","foi_nrPages":1},{"dc_format":"application/pdf;charset=UTF-8","dc_identifier":"nl.oorg10218.2e.2015.57.doc.4","dc_source":"https://www.gezondheidsraad.nl/binaries/gezondheidsraad/documenten/adviezen/2015/03/18/adriamycine/antwoordbrief_lentz_niosh_adriamycin_18_maart_2015.pdf","dc_title":"reactie Gezondheidsraad op commentaar van NIOSH op openbaar conceptrapport Adriamycine","dc_type":"bijlage","foi_doc_missing":1,"foi_fairiscoreVersions":{"v1":2,"v2":2},"foi_fileName":"antwoordbrief_lentz_niosh_adriamycin_18_maart_2015.pdf","foi_nrPages":2},{"dc_format":"application/pdf;charset=UTF-8","dc_identifier":"nl.oorg10218.2e.2015.57.doc.3","dc_source":"https://www.gezondheidsraad.nl/binaries/gezondheidsraad/documenten/adviezen/2015/03/18/adriamycine/comm_lentz_nioshandadr_adriamycin2015.pdf","dc_title":"commentaar op openbaar conceptrapport Adriamycine","dc_type":"bijlage","foi_doc_missing":1,"foi_fairiscoreVersions":{"v1":2,"v2":2},"foi_fileName":"comm_lentz_nioshandadr_adriamycin2015.pdf","foi_nrPages":5},{"dc_format":"application/pdf;charset=UTF-8","dc_identifier":"nl.oorg10218.2e.2015.57.doc.5","dc_source":"https://www.gezondheidsraad.nl/binaries/gezondheidsraad/documenten/adviezen/2015/03/18/adriamycine/Verzameling+belangenverklaringen+commissie+Gezondheid+en+beroepsmatige+blootstelling+aan+stoffen.pdf","dc_title":"verzameling belangenverklaringen commissie Gezondheid en beroepsmatige blootstelling aan stoffen","dc_type":"bijlage","foi_doc_missing":1,"foi_fairiscoreVersions":{"v1":4,"v2":4},"foi_fileName":"Verzameling+belangenverklaringen+commissie+Gezondheid+en+beroepsmatige+blootstelling+aan+stoffen.pdf","foi_nrPages":57}],"foi_isWoo":"Ja","foi_nrDocuments":5,"foi_nrPagesInDossier":120,"foi_page_title":"Advies Gezondheidsraad","foi_publishedDate":"2018-07-12","foi_retrievedDate":"2024-06-26","tooiwl_type":"c_99a836c7"},"resource":"nl.oorg10218.2e.2015.57"}